Perrigo Co PLC
PRGO
Company Profile
Business description
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm’s product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Contact
The Sharp Building
Hogan Place
DublinD02 TY74
IRLT: +353 17094000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
8,379
Stocks News & Analysis
stocks
Ask the analyst: Are markets missing something with CSL?
I catch up with Shane Ponraj after an eventful reporting season for healthcare major CSL.
stocks
This ASX stock’s bubble has well and truly burst
Pandemic related tailwinds are a distant memory for Reece, which looks set to face more competition in Australia.
stocks
Tesla’s stock is in trouble, but this fund manager sees a comeback in 2026
Tesla’s challenges echo past issues the company has overcome, says Zevenbergen’s Joe Dennison.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,231.10 | 2.60 | 0.03% |
CAC 40 | 7,741.41 | 31.60 | 0.41% |
DAX 40 | 24,120.66 | 32.21 | -0.13% |
Dow JONES (US) | 45,418.07 | 135.60 | 0.30% |
FTSE 100 | 9,268.94 | 3.14 | 0.03% |
HKSE | 25,201.76 | 323.16 | -1.27% |
NASDAQ | 21,544.27 | 94.98 | 0.44% |
Nikkei 225 | 42,520.27 | 125.87 | 0.30% |
NZX 50 Index | 12,861.84 | 96.14 | -0.74% |
S&P 500 | 6,465.94 | 26.62 | 0.41% |
S&P/ASX 200 | 8,960.50 | 0.70 | -0.01% |
SSE Composite Index | 3,800.35 | 68.03 | -1.76% |